Replies to post #2758 on Ocera Therapeutics fka OCRX

[shareholder_boar]

Messy yes, but the confusion might work to one's advantage in that you definitely have an out should the IRS investigate and disagree with your interpretation of the code.

In any event, the sales proceeds from the OCRX merger (or tender) will reflect $1.52/share on your 2017 1099.